COVID-19 Impact on the Indian Pharma Sector
Loading player...
On the back of the global pandemic as well as the Big Outperformance for the Indian Pharma sector over benchmark indices in recent times, the Investec Pharma team hosted a 7 Industry Experts Series over 5 Days in April. US, India & API businesses were central to discussions.
The series, which generated an overwhelming response among global investors, gave a very good perspective and a solid on-the-ground / transparent view across the pharma value chain during the COVID crises; not just the current situation but it also set investor expectations for the near future, which appears quite uncertain.
After a cautious approach for almost 5 years, Anshuman Gupta, pharma analyst, investec india turned positive in late February of 2020. Swapna Bhandarkar spoke with Anshuman on this
The series, which generated an overwhelming response among global investors, gave a very good perspective and a solid on-the-ground / transparent view across the pharma value chain during the COVID crises; not just the current situation but it also set investor expectations for the near future, which appears quite uncertain.
After a cautious approach for almost 5 years, Anshuman Gupta, pharma analyst, investec india turned positive in late February of 2020. Swapna Bhandarkar spoke with Anshuman on this
